Gilbert Lassalle

ORCID: 0009-0006-7863-6844
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Fibroblast Growth Factor Research
  • Blood Coagulation and Thrombosis Mechanisms
  • Oxidative Organic Chemistry Reactions
  • Atrial Fibrillation Management and Outcomes
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Synthetic Organic Chemistry Methods
  • Kruppel-like factors research
  • Organometallic Complex Synthesis and Catalysis
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Epigenetics and DNA Methylation
  • Cancer Treatment and Pharmacology
  • Advanced Synthetic Organic Chemistry
  • Proteoglycans and glycosaminoglycans research
  • Click Chemistry and Applications
  • Inorganic and Organometallic Chemistry
  • Asymmetric Synthesis and Catalysis
  • Synthesis and Reactivity of Heterocycles
  • Synthesis of heterocyclic compounds
  • Synthesis of β-Lactam Compounds
  • Chemical synthesis and pharmacological studies
  • Molecular spectroscopy and chirality
  • Chemical Synthesis and Reactions
  • Synthesis and Biological Evaluation
  • Helicobacter pylori-related gastroenterology studies

Sanofi (France)
2002-2014

The Ohio State University
1993-2003

Centre National de la Recherche Scientifique
1989-1990

Université de Rennes
1989-1990

Laboratoire de Chimie Organique
1990

École Nationale Supérieure de Chimie de Rennes
1990

Despite the importance of microbiota in human physiology, molecular bases that govern interactions between these commensal bacteria and their host remain poorly understood. We recently reported sulfatases play a key role adaptation major bacterium, Bacteroides thetaiotaomicron, to its (Benjdia, A., Martens, E. C., Gordon, J. I., Berteau, O. (2011) Biol. Chem. 286, 25973-25982). hypothesized are instrumental for this related species, metabolize highly sulfated glycans (i.e. mucins...

10.1074/jbc.m114.573303 article EN cc-by Journal of Biological Chemistry 2014-07-08

In the search of a potential backup for clopidogrel, we have initiated HTS campaign designed to identify novel reversible P2Y12 antagonists. Starting from hit with low micromolar binding activity, report here main steps optimization process leading identification preclinical candidate SAR216471. It is potent, highly selective, and receptor antagonist by far most potent inhibitor ADP-induced platelet aggregation among antagonists described in literature. SAR216471 displays vivo antiplatelet...

10.1021/jm500588w article EN Journal of Medicinal Chemistry 2014-07-30

Fibroblast growth factor (FGF) signaling regulates mammalian development and metabolism, its dysregulation is implicated in many inherited acquired diseases, including cancer. Heparan sulfate glycosaminoglycans (HSGAGs) are essential for FGF as they promote FGF.FGF receptor (FGFR) binding dimerization. Using novel organic synthesis protocols to prepare homogeneously sulfated heparin mimetics (HM), hexasaccharide (HM(6)), octasaccharide (HM(8)), decasaccharide (HM(10)), we tested the ability...

10.1074/jbc.m109.095109 article EN cc-by Journal of Biological Chemistry 2010-06-15

Compound 15 (SAR107375), a novel potent dual thrombin and factor Xa inhibitor resulted from rational optimization process. Starting compound 14, with low modest anti-thrombin inhibitory activities (IC50's of 3.5 0.39 μM, respectively), both were considerably improved, notably through the incorporation neutral chlorothiophene P1 fragment tuning P2 P3-P4 fragments. Final metabolic stability microsomes led to identification 15, which displays strong activity in vitro vs (with Ki's 1 8 nM,...

10.1021/jm4005835 article EN Journal of Medicinal Chemistry 2013-10-31

SSR182289A competitively inhibits human thrombin (K(i) = 0.031 +/- 0.002 microM) and shows good selectivity with respect to other proteases, e.g., trypsin 54 2 microM), factor Xa 167 9 VIIa, IXa, plasmin, urokinase, tPA, kallikrein, activated protein C (all K(i) values >250 microM). In plasma, demonstrated anticoagulant activity in vitro as measured by standard clotting parameters (EC100 time 96 7 nM) inhibited tissue factor-induced generation (IC50 of 0.15 0.02 thrombin-induced aggregation...

10.1124/jpet.102.040667 article EN Journal of Pharmacology and Experimental Therapeutics 2002-12-01

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTStudies directed toward the total synthesis of cerorubenic acid-III. 2. Analysis inability to realize D ring formation by means extraannular Robinson annulationLeo A. Paquette, Gilbert Y. Lassalle, and Carl J. LovelyCite this: Org. Chem. 1993, 58, 16, 4254–4261Publication Date (Print):July 1, 1993Publication History Published online1 May 2002Published inissue 1 July...

10.1021/jo00068a020 article EN The Journal of Organic Chemistry 1993-07-01

Abstract The easy transformation of pyrrolidine 4 in 5 and then into 7 shows that the diethylacetal 3‐cyano 2‐propenal can be considered as a useful synthetic equivalent functionnalized heterocumulenes 2 3.

10.1002/bscb.19890981209 article EN Bulletin des Sociétés Chimiques Belges 1989-01-01

Abstract The 1,2,5‐triphenyl‐3,4‐cis‐divinylpyrrolidine (I) reacts with iron pentacarbonyl (II) to give the triphenyldiethylpyrrole (III) and vinylpyrroline (IV).

10.1002/chin.199042189 article EN ChemInform 1990-10-16

Abstract ChemInform is a weekly Abstracting Service, delivering concise information at glance that was extracted from about 100 leading journals. To access of an article which published elsewhere, please select “Full Text” option. The original trackable via the “References”

10.1002/chin.199349139 article EN ChemInform 1993-12-07
Coming Soon ...